Status:
COMPLETED
Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients
Lead Sponsor:
AstraZeneca
Conditions:
Dyslipidemias
Eligibility:
All Genders
18+ years
Brief Summary
An observational, non-interventional, multi-centre study to provide further information on the ratio of LDL-C to HDL-C improvement after statin treatment in Korean patients group.
Eligibility Criteria
Inclusion
- Subjects who are taking lipid-lowering medication after diagnosed as dyslipidaemia
- Subjects who have at least made 1 visit to the outpatient clinic within previous 6 months
- Subjects who have records of both LDL-C and HDL-C before \& after statin treatment (at least four weeks after statin taking)
Exclusion
- Subjects who are unwilling or unable to provide their examination and lab result of medical chart.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2009
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT00931320
Start Date
July 1 2009
End Date
September 1 2009
Last Update
October 27 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.